Shares of Celadon Pharmaceuticals Plc (LON:CEL – Get Free Report) traded up 10.2% on Wednesday . The company traded as high as GBX 27 ($0.33) and last traded at GBX 23.70 ($0.29). 115,646 shares changed hands during mid-day trading, a decline of 73% from the average session volume of 424,960 shares. The stock had previously closed at GBX 21.50 ($0.27).
Celadon Pharmaceuticals Stock Up 16.3 %
The company has a current ratio of 1.92, a quick ratio of 6.97 and a debt-to-equity ratio of 194.82. The firm has a 50 day moving average price of GBX 17.47 and a 200-day moving average price of GBX 32.02. The firm has a market cap of £17.21 million, a price-to-earnings ratio of -312.50 and a beta of -0.26.
Celadon Pharmaceuticals Company Profile
Celadon Pharmaceuticals Plc is a UK-based pharmaceutical company focused on the development, production and sale of breakthrough cannabis-based medicines. Its primary focus is on improving quality of life for chronic pain sufferers, as well as exploring the potential of cannabis-based medicines for other conditions such as autism.
Featured Articles
- Five stocks we like better than Celadon Pharmaceuticals
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Market Momentum: 3 Stocks Poised for Significant Breakouts
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Kinder Morgan’s Uptrend is Only Half Over: New Highs Are Coming
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Momentum Builders: 3 Stocks Positioned to Shine This Quarter
Receive News & Ratings for Celadon Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celadon Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
